Thermogenesis Holdings Investor Relations Material
Latest events
Q3 2023
Thermogenesis Holdings
Q1 2024
17 May, 2024
Q4 2023
16 Apr, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Thermogenesis Holdings Inc
Access all reports
ThermoGenesis Holdings, Inc. previously known as Cesca Therapeutics Inc., is a developer in automated cell processing technologies for the cell and gene therapy sector. The company, through its subsidiary ThermoGenesis Corp., offers comprehensive solutions for automated clinical biobanking, point-of-care applications, and large-scale cell processing and manufacturing, particularly for the emerging CAR-T immunotherapy market. Thermogenesis Holdings, Inc. was founded in 1986 and is headquartered in Rancho Cordova, California, with its shares listed on the Nasdaq stock exchange.
Latest articles
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
)
Novo Nordisk: Tipping the Scale of Innovation
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces
8 Aug 2025
Ticker symbol
THMO
Country
🇺🇸 United States